Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0349-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BRCA Mutations in Women With Inflammatory Breast Cancer

Cancer
Cancer ResearchOncology
2017English

BRCA Mutation Breast Cancer Patients Show Equivalent Ovarian Reserve and Response to IVF Stimulation Compared to BRCA Negative Patients and Other Malignancies Undergoing Fertility Preservation

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2017English

Non- BRCA Familial Breast Cancer: Review of Reported Pathology and Molecular Findings

Pathology
Forensic MedicinePathology
2017English

BRCA Mutations in the Manifestation and Treatment of Ovarian Cancer

Oncotarget
Oncology
2017English

UK BRCA Mutation Testing in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

BRCA and Early Events in the Development of Serous Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2014English

P2: SNP Analysis in Brca Positive and Brca Negative Subjects With and Without Breast Cancer (Brca) Reveal Central Role of Alk SNPS and Tgfbeta Superfamily in Malignant Transformation

Journal of Investigative Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors

Frontiers in Oncology
Cancer ResearchOncology
2014English

The Value of BRCA 1 Gene Mutation in Patients With Breast Cancer

Sohag Medical Journal
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy